Catalent, Inc. (CTLT)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Catalent, Inc. (“Catalent” or “the Company”) (NYSE: CTLT) in regards to the sale of Catalent to Novo Holdings for $63.50 per share in cash is fair to Catalent shareholders. Investors who purchased Catalent securities are encouraged to obtain additional information and assist in the investigation.
Investigation Details:
The investigation concerns whether Catalent and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible consideration for Catalent shareholders; (2) determine whether Novo Holdings is underpaying for Catalent; and (3) disclose all material information necessary for Catalent shareholders to adequately assess and value the merger consideration.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Catalent shares, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson